These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33850679)

  • 1. Opioid-Induced Constipation in Advanced Cancer Patients.
    ALMouaalamy N
    Cureus; 2021 Apr; 13(4):e14386. PubMed ID: 33850679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Overview and Considerations for the Management of Opioid-induced Constipation in Patients With Chronic Noncancer Pain.
    Viscusi ER
    Clin J Pain; 2019 Feb; 35(2):174-188. PubMed ID: 30289777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM; Bilsky EJ
    J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
    Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
    Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid-induced Constipation: Old and New Concepts in Diagnosis and Treatment.
    Squeo F; Celiberto F; Ierardi E; Russo F; Riezzo G; D'Attoma B; Di Leo A; Losurdo G
    J Neurogastroenterol Motil; 2024 Apr; 30(2):131-142. PubMed ID: 38576366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Peripherally Acting μ-Opioid Receptor Antagonist (PAMORAs) for the Management of Patients With Opioid-Induced Constipation: A Systematic Review.
    Rekatsina M; Paladini A; Drewes AM; Ayob F; Viswanath O; Urits I; Corli O; Pergolizzi J; Varrassi G
    Cureus; 2021 Jul; 13(7):e16201. PubMed ID: 34367804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naldemedine in Japanese patients with opioid-induced constipation and chronic noncancer pain: open-label Phase III studies.
    Saito Y; Yokota T; Arai M; Tada Y; Sumitani M
    J Pain Res; 2019; 12():127-138. PubMed ID: 30613161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer.
    Katakami N; Harada T; Murata T; Shinozaki K; Tsutsumi M; Yokota T; Arai M; Tada Y; Narabayashi M; Boku N
    Ann Oncol; 2018 Jun; 29(6):1461-1467. PubMed ID: 32151367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constipation in Cancer Patients - an Update of Clinical Evidence.
    Dzierżanowski T; Mercadante S
    Curr Treat Options Oncol; 2022 Jul; 23(7):936-950. PubMed ID: 35441979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety.
    Pergolizzi JV; Christo PJ; LeQuang JA; Magnusson P
    Drug Des Devel Ther; 2020; 14():1009-1025. PubMed ID: 32210534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
    De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
    Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' Self-Assessment of the Symptoms and Impact of Opioid-Induced Constipation: Results From a Prospective Observational Cohort Study of Japanese Patients With Cancer.
    Fumita S; Imai H; Harada T; Noriyuki T; Gamoh M; Akashi Y; Sato H; Kizawa Y; Tokoro A
    J Pain Symptom Manage; 2020 May; 59(5):1043-1051.e2. PubMed ID: 31805362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Peripherally Acting Mu-Opioid Receptor Antagonists for the Treatment of Opioid-Induced Constipation: A Bayesian Network Meta-analysis.
    Ouyang R; Li Z; Huang S; Liu J; Huang J
    Pain Med; 2020 Nov; 21(11):3224-3232. PubMed ID: 32488259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of naloxegol in the treatment of opioid-induced constipation.
    Bruner HC; Atayee RS; Edmonds KP; Buckholz GT
    J Pain Res; 2015; 8():289-94. PubMed ID: 26109876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-induced Constipation: A Review of Health-related Quality of Life, Patient Burden, Practical Clinical Considerations, and the Impact of Peripherally Acting μ-Opioid Receptor Antagonists.
    Argoff CE
    Clin J Pain; 2020 Sep; 36(9):716-722. PubMed ID: 32554978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of opioid-induced constipation.
    Prichard D; Norton C; Bharucha AE
    Br J Nurs; 2016 May 26-Jun 8; 25(10):S4-5, S8-11. PubMed ID: 27231750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
    Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study.
    Cobo Dols M; Beato Zambrano C; Cabezón-Gutiérrez L; Chicas-Sett R; Blancas López-Barajas MI; García Navalón FJ; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Huerta González I; Sanz-Yagüe A; Soler López B
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e318-e326. PubMed ID: 33707299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.